Showing results (91-100 of 540) with videos related to

Sort By:
Pageof 54
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Renal cell carcinoma in transplant recipients with acquired cystic kidney diseaseAnke Schwarz, Serap Vatandaslar, Saskia Merkel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 13, 2010
The podocyte as a direct target of immunosuppressive agentsEva Schönenberger, Jochen H Ehrich, Hermann Haller, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 9, 2019
Are ISPD Guidelines on Peritonitis Diagnosis Too Narrow? A 15-Year Retrospective Single-Center Cohort Study on PD-Associated Peritonitis Accounting for Untrained PatientsMichael S Balzer, Robert Claus, Hermann Haller, et al.
Journal of the American Society of Nephrology : JASN|January 3, 2001
Role of mitogen-activated protein kinases in activation of human neutrophils by antineutrophil cytoplasmic antibodiesRalph Kettritz, Adrian Schreiber, Friedrich C Luft, et al.
Blood Purification|March 20, 2014
Online Kt/V monitoring in haemodialysis by UV absorbance: variations during intra-dialytic mealsJanina Müller-Deile, Ralf Lichtinghagen, Hermann Haller, et al.
Nature Clinical Practice. Cardiovascular Medicine|September 23, 2006
Mechanisms of disease: erythropoietin--an old hormone with a new mission?Danilo Fliser, Ferdinand H Bahlmann, Kirsten deGroot, et al.
International Journal of Molecular Sciences|January 21, 2022
The Therapeutic Potential of Zinc-Alpha2-Glycoprotein (AZGP1) in Fibrotic Kidney DiseaseInga Sörensen-Zender, Song Rong, Hermann Haller, et al.
American Journal of Nephrology|September 2, 2019
Comparison of Different Selection Strategies for Tolvaptan Eligibility among Autosomal Dominant Polycystic Kidney Disease PatientsVera C Wulfmeyer, Bernd Auber, Hermann Haller, et al.
European Journal of Cell Biology|April 15, 2003
Integrin alphavbeta3 binding to human alpha5-laminins facilitates FGF-2- and VEGF-induced proliferation of human ECV304 carcinoma cellsElke Genersch, Maria Ferletta, Ismo Virtanen, et al.
Pageof 54